Omeros (OMER) Inventory Average (2015 - 2021)
Omeros recorded quarterly Inventory Average of $845000.0 in Q3 2021, down 22.08% quarter-over-quarter from $1.1 million in Q2 2021, and down 50.79% year-over-year from $1.7 million in Q3 2020.
Omeros' Inventory Average history runs 7 years deep, the most recent figure standing at $845000.0 for Q3 2021.
- In Q3 2021, Inventory Average fell 50.79% year-over-year to $845000.0; the TTM figure through Sep 2021 stood at $845000.0 (down 50.79% YoY), while the FY2020 annual figure was $1.3 million, up 102.59% from the prior year.
- Inventory Average came in at $845000.0 for Q3 2021 at Omeros, down from $1.1 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $1.7 million in Q3 2020 to a low of $151000.0 in Q4 2018.
- A 5-year average of $907684.2 and a median of $961500.0 in 2019 frame the typical range for Inventory Average.
- Across the five-year window, Inventory Average tumbled 76.13% in 2018 and soared 668.21% in 2019, its largest moves.
- Omeros' Inventory Average stood at $632500.0 in 2017, then sank by 76.13% to $151000.0 in 2018, then jumped by 668.21% to $1.2 million in 2019, then rose by 24.87% to $1.4 million in 2020, then slumped by 41.66% to $845000.0 in 2021.
- According to Business Quant data, Inventory Average over the past three periods registered $845000.0, $1.1 million, and $1.3 million for Q3 2021, Q2 2021, and Q1 2021 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 30.59 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.73 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.15 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 83.37 Mn |
| 10 | Omeros | 772.03 Mn | 636.71 Mn | 9.31 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 845,000.00 |
| Jun 30, 2021 | 1.08 Mn |
| Mar 31, 2021 | 1.27 Mn |
| Dec 31, 2020 | 1.45 Mn |
| Sep 30, 2020 | 1.72 Mn |
| Jun 30, 2020 | 1.55 Mn |
| Mar 31, 2020 | 1.18 Mn |
| Dec 31, 2019 | 1.16 Mn |
| Sep 30, 2019 | 1.18 Mn |
| Jun 30, 2019 | 961,500.00 |
| Mar 31, 2019 | 412,000.00 |
| Dec 31, 2018 | 151,000.00 |
| Sep 30, 2018 | 224,500.00 |
| Jun 30, 2018 | 241,000.00 |
| Mar 31, 2018 | 345,000.00 |
| Dec 31, 2017 | 632,500.00 |
| Sep 30, 2017 | 863,500.00 |
| Jun 30, 2017 | 932,500.00 |
| Mar 31, 2017 | 1.04 Mn |
| Dec 31, 2016 | 1.26 Mn |
| Sep 30, 2016 | 1.59 Mn |
| Jun 30, 2016 | 1.88 Mn |
| Mar 31, 2016 | 1.22 Mn |
| Dec 31, 2015 | 458,500.00 |
| Sep 30, 2015 | 539,000.00 |
| Jun 30, 2015 | 599,500.00 |
| Mar 31, 2015 | 567,000.00 |